1. Home
  2. MCBS vs FTRE Comparison

MCBS vs FTRE Comparison

Compare MCBS & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCBS
  • FTRE
  • Stock Information
  • Founded
  • MCBS 2006
  • FTRE 1996
  • Country
  • MCBS United States
  • FTRE United States
  • Employees
  • MCBS N/A
  • FTRE N/A
  • Industry
  • MCBS Major Banks
  • FTRE Medical Specialities
  • Sector
  • MCBS Finance
  • FTRE Health Care
  • Exchange
  • MCBS Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • MCBS 654.0M
  • FTRE 864.4M
  • IPO Year
  • MCBS 2019
  • FTRE N/A
  • Fundamental
  • Price
  • MCBS $25.76
  • FTRE $10.10
  • Analyst Decision
  • MCBS Hold
  • FTRE Hold
  • Analyst Count
  • MCBS 1
  • FTRE 9
  • Target Price
  • MCBS $31.00
  • FTRE $13.06
  • AVG Volume (30 Days)
  • MCBS 40.6K
  • FTRE 984.4K
  • Earning Date
  • MCBS 10-17-2025
  • FTRE 11-05-2025
  • Dividend Yield
  • MCBS 3.88%
  • FTRE N/A
  • EPS Growth
  • MCBS 11.15
  • FTRE N/A
  • EPS
  • MCBS 2.59
  • FTRE N/A
  • Revenue
  • MCBS $147,349,000.00
  • FTRE $2,733,500,000.00
  • Revenue This Year
  • MCBS $18.90
  • FTRE N/A
  • Revenue Next Year
  • MCBS $27.50
  • FTRE N/A
  • P/E Ratio
  • MCBS $9.96
  • FTRE N/A
  • Revenue Growth
  • MCBS 8.69
  • FTRE N/A
  • 52 Week Low
  • MCBS $24.24
  • FTRE $3.97
  • 52 Week High
  • MCBS $36.15
  • FTRE $25.28
  • Technical
  • Relative Strength Index (RSI)
  • MCBS 38.44
  • FTRE 50.98
  • Support Level
  • MCBS $25.14
  • FTRE $9.72
  • Resistance Level
  • MCBS $26.64
  • FTRE $10.91
  • Average True Range (ATR)
  • MCBS 0.61
  • FTRE 0.63
  • MACD
  • MCBS 0.01
  • FTRE -0.05
  • Stochastic Oscillator
  • MCBS 28.05
  • FTRE 41.30

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: